Clinical trials: Brain Metastasases

Triple Negative Breast Cancer (TNBC), Brain Metastasases

JK-1201I in Triple Negative Breast Cancer Patients with Brain Metastases

• Unknown status
• Age: 18 years and older
• Phase 2

This study was designed to evaluate the safety, efficacy and pharmacokinetics of JK-1201I in triple negative breast cancer patients with brain metastases.

Trial name

NCT06586866

Testing

JK-1201I

Volunteers

25 people

Sponsor

JenKem Technology Co., Ltd.